At nanomolar concentrations, phorbol 12-myristate 13-acetate induced differentiation in a human Epstein-Barr virus-negative B-cell line, JD 38, derived from an undifferentiated lymphoma and containing an 8;14 translocation. The changes induced by phorbol 12-myristate 13-acetate were consistent with differentiation towards plasma cells and included (i) a marked increase (30-fold) in IgM secretion; (it) a decrease in the nuclear/cytoplasmic ratio associated with the development of a single prominent nucleolus instead of multiple nucleoli; (iii) the development of parallel arrays of rough endoplasmic reticulum, eccentric nuclei, and marginated heterochromatin; (iv) a reduction in the expression of surface markers, including common acute lymphoblastic leukemia antigen, IgM, and C3 receptors. Essentially all cells showed plasmacytoid differentiation, although the degree varied. Rare cells (<1%) appeared to be terminally differentiated into plasma cells. The increase in secreted IgM was preceded by a small increase in ,u-chain RNA, with an increase in the ratio of secreted to membrane form. A small increase in c-myc RNA was also detected with differentiation. This might reflect coordinate regulation of the transcription of immunoglobulin and the translocated c-myc gene. Thus, the maturational arrest of this lymphoma cell line can be overcome with phorbol 12-myristate 13-acetate, indicating that translocation of the c-myc gene does not permanently block the capacity for differentiation. Further, this gene continues to be expressed to at least the same level during cell maturation. Similar ultrastructural changes were induced by phorbol 12-myristate 13-acetate in four of seven additional lines studied.
Considerable evidence has been compiled that supports the hypothesis that failure of differentiation with resultant accumulation of less differentiated cells may be of pathogenetic significance in the development of human hematopoietic malignancies, including Burkitt lymphoma (1, 2) . Burkitt lymphomas and the closely related undifferentiated non-Burkitt lymphomas almost invariably contain a reciprocal chromosomal translocation involving the terminal portion of the long arm of chromosome 8 and one of the chromosomal locations of the immunoglobulin genes (3). c-myc, the cellular equivalent of the v-myc oncogene of the MC29 virus, has been shown to reside in this terminal (q24 -> qter) region of chromosome 8 in man and, in some cases, has been shown directly to be translocated into the heavy chain region in cell lines that contain an 8;14 chromosomal translocation (4) . It is probable that altered expression of c-myc, presumably brought about by the proximity of c-myc to an immunoglobulin gene as a consequence of the chromosomal translocation, is a critical component of the pathogenesis of Burkitt lymphoma. This is supported by the occurrence of analogous abnormalities in mouse plasmacytomas (5, 6) . Because of the possibility that the genetic rearrangements in Burkitt lymphoma cells are responsible for the differentiation failure, it was of particular interest to determine whether the defect in differentiation was reversible and whether, in the event that differentiation could be induced, c-myc gene transcription would be altered compared to the uninduced cells.
Of the various chemical agents that have been shown to induce cellular differentiation in vitro (7, 8) , one of the most potent is phorbol 12-myristate 13-acetate (PMA) . Recent reports have provided evidence that PMA can induce differentiation of human leukemia cells, including those of acute myeloid leukemia (9) , chronic lymphocytic leukemia (10) , and acute lymphoblastic leukemia (11) .
We have studied the effect of PMA in detail on a cell line (JD 38) derived from a malignant undifferentiated lymphoma of non-Burkitt type (modified Rappaport classification) that contains an 8;14 translocation. The JD 38 line was induced to undergo morphologic and functional changes consistent with differentiation towards a plasma cell. Changes in C, and cmyc mRNAs will be described and discussed. We have also studied other undifferentiated lymphoma-derived cell lines of both Burkitt and non-Burkitt type and have observed PMA-induced morphological changes similar to those seen in JD 38 cells.
MATERIALS AND METHODS
Cells and Cell Culture. JD 38 is an Epstein-Barr virus (EBV)-negative cell line derived in our laboratory from tumor cells circulating in the peripheral blood in a 3-year-old male child with recurrent undifferentiated non-Burkitt lymphoma (12) . The cell line contains an 8;14 chromosomal translocation (13) and expresses C3 receptors (14) , common acute lymphoblastic leukemia antigen (CALLA), p2-microglobulin, and HLA-DR antigens (unpublished data). JD 38 cells also express surface IgM/K and secrete IgM/K (15), as did the original neoplastic cells, but do not exhibit plasmacytoid features. The other cell lines used in this study have been described elsewhere (15) . The cell lines were maintained as suspension cultures as described (15) .
Cells obtained on the 4th day after subculture were resuspended in fresh medium at a concentration of 5 x 105 cells per ml and incubated at 37°C in 5% CO2 in air for 1-6 days in the presence of a broad range of PMA (P-L Biochemicals) concentrations (0.1 ,uM 0.01 nM) or no PMA.
Quantitation of Ig Secretion and Cytoplasmic Ig Assay. Culture supernatants were assayed for IgM by an ELISA using an alkaline phosphatase-coupled antibody to human IgM (Sigma). Cytoplasmic IgM was assessed with a rhodamineAbbreviations: PMA, phorbol 12-myristate 13-acetate; EBV, Epstein-Barr virus; kb, kilobase(s); CALLA, common acute lymphoblastic leukemia antigen. tTo whom reprint requests should be addressed.
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Other cell surface antigens were detected with monoclonal antibodies, using indirect immunofluorescence and flow cytometry as described (16 paper, and hybridized with genomic probes of the human joining heavy region (JH), constant u region (C,), and c-myc (17, 18) .
Cytoplasmic RNA was extracted at serial time points of 0, 3, 6, 9, and 24 hr and 4 days from equal numbers of JD 38 cells cultured both in the presence and absence of PMA (19) . Serial dilutions of the cytoplasmic RNA from a given number of cells were dotted on nitrocellulose using a 96-well suction manifold. In addition, total cellular RNA was extracted by utilizing a guanidine thiocyanate procedure from JD 38 cells both in the presence and absence of PMA at times of 0 and 24 hr and 4 days. Ten micrograms of the total RNA was electrophoresed through formaldehyde gels and transferred to nitrocellulose for analysis with specific DNA probes (20) . Poly(A) RNA was prepared from -2 mg of the total cellular RNA by selection over an oligo(dt)-cellulose column (21) . Serial dilutions of this poly(A) RNA were dot blotted onto nitrocellulose. All nitrocellulose filters were baked and hybridized to either the C., membrane exon (pu), or c-myc probe (22) . Serial autoradiograms within the linear dose-response range of the film were developed and the intensity of hybridization was assessed by densitometric scanning with a DU-8 spectrophotometer (Beckman). In addition, the exact intensity of hybridization of c-myc to the poly(A) RNA dot blots was determined by scintillation spectroscopy of each hybridized RNA sample. (15) . In the presence of PMA (optimal concentration, 10 nM), there was a marked increase in the secretion of IgM (Fig. 1) , up to a maximum of 30-fold on the 4th day of subculturing.
Morphological Changes Induced After PMA Treatment. Light microscopy. A marked difference between control and PMA-treated cells was apparent in Romanowski-stained cell smears. PMA-treated cells were larger, due to a decrease in the nuclear/cytoplasmic ratio and developed a single large nucleolus. Occasionally, cells closely resembled mature plasma cells (Fig. 2) .
Transmission electron microscopy. Transmission electron microscopy, on the 3rd day after subculture, revealed unequivocal differences between PMA-treated and control JD 38 cells. Untreated cells exhibited a lymphoblastic appearance with little rough endoplasmic reticulum or Golgi development. The cytoplasm was filled with free polyribosomes, and nuclei were generally irregular, centrally placed, and contained little peripheral heterochromatin (Fig. 3A) . In contrast, the PMA-treated cells manifested a striking plasmacytoid appearance, which was present in both floating and adherent cells (Fig. 3 B and C) . Eccentric nuclei with prominent nucleoli, a regular border, and marginated heterochromatin were frequently seen; cytoplasmic maturation was evidenced by the appearance of numerous parallel arrays of rough endoplasmic reticulum, occasionally so pronounced that the cells resembled malignant plasma cells. Free ribosomes were reduced in number.
We have studied seven additional undifferentiated lymphoma cell lines of both Burkitt and non-Burkitt origin and also EBV and non-EBV associated. All contain 8;14 translocations. Four of these lines showed ultrastructural changes similar to those observed in JD 38, although to varying degrees. The most marked changes-essentially identical to those observed in JD 38-were seen in an African Burkitt lymphoma line, Namalwa (EBV positive), and an American Burkitt lymphoma line, CA 46 (EBV negative) (15) . able from plasma cells (Fig. 4D) (23) . The other rearrangement is an aberrant rearrangement of the immunoglobulin gene allele that is associated with the translocation of chromosome 8. In JD 38 the translocation of c-myc to the 14q+ chromosome has resulted in a detectable rearrangement around the c-myc gene that is observed in both EcoRI and BamHI digests (24) . There were no differences in the configuration of immunoglobulin or c-myc genes following PMA, which could account for the changes observed in IgM secretion or plasma-
Analysis of Immunoglobulin and c-myc RNA. To investigate the potential mechanism responsible for the enhanced IgM secretion seen by JD 38 following PMA stimulation, a serial time course of cytoplasmic ,u-chain RNA was assessed (Fig. 5 a and b) . The specific ,u-chain RNA within the same numbers of cells, cultured in the presence or absence of PMA, was determined in triplicate at time points 0, 3, 6, 9, and 24 hr and 4 days. An increment in u-chain RNA was detectable as early as 3 hr after PMA and plateaued at an -35% increase by 24 hr (Fig. 5 a and b) . Electrophoresis and blot analysis of total cellular RNA after 24 hr of culture in the presence or absence of PMA also revealed an increase in ,-chain RNA with PMA. Hybridization with the , membrane (4m) exon probe revealed no significant change in the amount of ,-chain RNA after PMA stimulation (Fig. 5c) . Therefore, the increment in ,t-chain RNA noted following PMA stimulation appears to be predominantly of the 2.4-kilobase (kb) ,u-secreted (p.) species. The expression of cmyc in JD 38 has been shown to be slightly increased (-2-fold) when compared to B-cell lines without translocations (25) . If (2) . The uniform "blast-like" cytological appearance of these tumors raises the possibility that an essential aspect of their pathogenesis is differentiation failure, and, indeed, in several other neoplasms, there is evidence that this is the case (2, 11, 26) .
In the present report we present evidence that cell lines derived from undifferentiated lymphomas, including Burkitt lymphoma, can be induced to undergo plasmacytoid differentiation by PMA. Our evidence is based upon both structural changes in the cells, as demonstrated by light and electron microscopy, and functional changes-namely, an increase in IgM secretion. In JD 38, a reduction in the expression of cell surface antigens, including CALLA, OKT-10, and surface IgM, accompanied these changes, although at present we cannot conclude that this is entirely due to differentiation. Alterations in the cell cycle might also account for such changes. Nearly all JD 38 cells cultured with PMA had a plasmacytoid appearance by light and electron microscopy, and some were essentially indistinguishable from malignant plasma cells as seen in multiple myeloma. The expression of cytoplasmic IgM was entirely consistent with these findings.
Although a high proportion of the cells also became adherent to a plastic surface in the presence of PMA, we do not know the significance of this phenomenon. The presence of nonspecific esterases in B cells has been reported previously, and the increase seen in PMA-treated JD 38 cells is also consistent with differentiation into more mature B cells (27) .
The demonstrated increase in IgM secretion in PMA-treated JD 38 cells led to a study of qualitative and quantitative changes in A-chain mRNA species induced by PMA. The increases in A-chain RNA, predominantly of the 2.4-kb , species, clearly preceded the increased secretion of IgM. This change is consistent with our interpretation that plasmacytoid differentiation was induced in JD 38 by PMA since plasmacytomas selectively produce more , than p, mRNA (28) . The precise mechanisms accounting for this accumulation of i-chain RNA are not certain, as pulse-chase kinetic experiments were not performed here. However, the very early increase in A-chain RNA after addition of PMA to the cultures suggests that an actual increase in transcription is at least partially responsible. As the secretion rate of IgM increased roughly 30-fold and the increment in p-chain RNA was only 35%, it is likely that a major portion of the increased secretion of IgM is mediated by post-transcriptional events, especially translational control. In this regard, it is pertinent that in our studies in this and similar cell lines, the induction of IgM secretion was always associated with a marked increase in rough endoplasmic reticulum as visualized by electron microscopy. Rough endoplasmic reticulum is known to be associated with the production of protein for export from the cell.
An uncoupling of growth and differentiation has been noted in a variety of malignancies. One aspect of this is a maturational arrest that maintains the neoplastic cells at a certain stage of development. Treatment with a phorbol ester overcame the relative arrest in several of our undifferentiated lymphoma cell lines and induced maturation to a more actively secreting, plasmacytoid B cell. If the c-myc cellular oncogene product was responsible for maintaining the arrested stage of development, a decrease in c-myc RNA might be anticipated during the induction of differentiation, as has been observed with the HL-60 cell line when differentiation is induced-e.g., with dimethyl sulfoxide (29) . In fact, a small increase in c-myc RNA levels was noted in JD 38 following differentiation, suggesting that increased expression of c-myc is not responsible for the maturational arrest of these tumor cells. It is known that in several cell lines studied to date the c-myc gene has been introduced by translocation into the heavy chain gene region on the 14q+ chromosome (18, 23 
